A citation-based method for searching scientific literature

Hans Van Eenennaam, Judith H P Vogelzangs, Dorien Lugtenberg, Frank H J Van Den Hoogen, Walther J Van Venrooij, Ger J M Pruijn. Arthritis Rheum 2002
Times Cited: 39







List of co-cited articles
611 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
Ghaith M Mitri, Mary Lucas, Noreen Fertig, Virginia D Steen, Thomas A Medsger. Arthritis Rheum 2003
114
51


Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations.
H Van Eenennaam, J H P Vogelzangs, L Bisschops, L C J Te Boome, H P Seelig, M Renz, D-J De Rooij, R Brouwer, H Pluk, G J M Pruijn,[...]. Clin Exp Immunol 2002
44
41

Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
M Kuwana, K Kimura, M Hirakata, Y Kawakami, Y Ikeda. Ann Rheum Dis 2002
32
46


Autoantibodies in systemic sclerosis.
Virginia D Steen. Semin Arthritis Rheum 2005
384
30

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
U A Walker, A Tyndall, L Czirják, C Denton, D Farge-Bancel, O Kowal-Bielecka, U Müller-Ladner, C Bocelli-Tyndall, M Matucci-Cerinic. Ann Rheum Dis 2007
513
25

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.
F C Arnett, J D Reveille, R Goldstein, K M Pollard, K Leaird, E A Smith, E C Leroy, M J Fritzler. Arthritis Rheum 1996
136
23

Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
Rick Brouwer, Wilma T M Vree Egberts, Gerald J D Hengstman, Reinout Raijmakers, Baziel G M van Engelen, Hans Peter Seelig, Manfred Renz, Rudolf Mierau, Ekkehard Genth, Ger J M Pruijn,[...]. Arthritis Res 2002
66
23


Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.
Clodoveo Ferri, Gabriele Valentini, Franco Cozzi, Marco Sebastiani, Claudio Michelassi, Giovanni La Montagna, Arianna Bullo, Massimiliano Cazzato, Enrico Tirri, Franca Storino,[...]. Medicine (Baltimore) 2002
516
20


Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.
Paul Q Hu, Noreen Fertig, Thomas A Medsger, Timothy M Wright. Arthritis Rheum 2003
101
20

Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex.
Tim J M Welting, Walther J van Venrooij, Ger J M Pruijn. Nucleic Acids Res 2004
71
20

Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis.
Aryeh Fischer, Frederick J Pfalzgraf, Carol A Feghali-Bostwick, Timothy M Wright, Douglas Curran-Everett, Sterling G West, Kevin K Brown. J Rheumatol 2006
52
20


High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients.
J H Shero, B Bordwell, N F Rothfield, W C Earnshaw. Science 1986
314
17



Purification and characterization of Rpp25, an RNA-binding protein subunit of human ribonuclease P.
Cecilia Guerrier-Takada, Paul S Eder, Venkat Gopalan, Sidney Altman. RNA 2002
36
19

Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia.
M Ridanpää, H van Eenennaam, K Pelin, R Chadwick, C Johnson, B Yuan, W vanVenrooij, G Pruijn, R Salmela, S Rockas,[...]. Cell 2001
297
17

The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis.
R Hesselstrand, A Scheja, G Q Shen, A Wiik, A Akesson. Rheumatology (Oxford) 2003
106
17

RNase MRP cleaves the CLB2 mRNA to promote cell cycle progression: novel method of mRNA degradation.
Tina Gill, Ti Cai, Jason Aulds, Sara Wierzbicki, Mark E Schmitt. Mol Cell Biol 2004
115
17

RNA-protein interactions in the human RNase MRP ribonucleoprotein complex.
H Pluk, H van Eenennaam, S A Rutjes, G J Pruijn, W J van Venrooij. RNA 1999
54
17

Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
Angela Ceribelli, Ilaria Cavazzana, Franco Franceschini, Paolo Airò, Angela Tincani, Roberto Cattaneo, Brad A Pauley, Edward K L Chan, Minoru Satoh. J Rheumatol 2010
36
19

Update on autoantibodies in systemic sclerosis.
Jennifer G Walker, Marvin J Fritzler. Curr Opin Rheumatol 2007
45
17

Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
Noreen Fertig, Robyn T Domsic, Tatiana Rodriguez-Reyna, Masataka Kuwana, Mary Lucas, Thomas A Medsger, Carol A Feghali-Bostwick. Arthritis Rheum 2009
71
17

South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
Scott W Graf, Paul Hakendorf, Sue Lester, Karen Patterson, Jenny G Walker, Malcolm D Smith, Michael J Ahern, Peter J Roberts-Thomson. Int J Rheum Dis 2012
59
17


Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
Rudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, Inga Melchers, Michael Meurer, Frank Reichenberger, Michael Buslau, Margitta Worm, Norbert Blank, Rüdiger Hein,[...]. Arthritis Res Ther 2011
76
17

Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
Danilo Villalta, Tiziana Imbastaro, Sabrina Di Giovanni, Ciro Lauriti, Marco Gabini, Maria Costanza Turi, Nicola Bizzaro. Autoimmun Rev 2012
61
17

Autoantibodies in systemic sclerosis.
Sonal Mehra, Jennifer Walker, Karen Patterson, Marvin J Fritzler. Autoimmun Rev 2013
129
17

Autoantibody reactive with RNA polymerase III in systemic sclerosis.
Y Okano, V D Steen, T A Medsger. Ann Intern Med 1993
168
15


Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus.
H A Gussin, G P Ignat, J Varga, M Teodorescu. Arthritis Rheum 2001
52
15

HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.
D Falkner, J Wilson, T A Medsger, P A Morel. Arthritis Rheum 1998
32
18

Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
C C Bunn, C P Denton, X Shi-Wen, C Knight, C M Black. Br J Rheumatol 1998
124
15

A long-term longitudinal study of anticentromere antibodies.
H D Tramposch, C D Smith, J L Senecal, N Rothfield. Arthritis Rheum 1984
99
15



Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
C V Oddis, Y Okano, W A Rudert, M Trucco, R J Duquesnoy, T A Medsger. Arthritis Rheum 1992
150
15

Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants.
J D Reveille, M Fischbach, T McNearney, A W Friedman, M B Aguilar, J Lisse, M J Fritzler, C Ahn, F C Arnett. Semin Arthritis Rheum 2001
175
15

Characterization of two scleroderma autoimmune antigens that copurify with human ribonuclease P.
P S Eder, R Kekuda, V Stolc, S Altman. Proc Natl Acad Sci U S A 1997
90
15


Accurate processing of a eukaryotic precursor ribosomal RNA by ribonuclease MRP in vitro.
Z Lygerou, C Allmang, D Tollervey, B Séraphin. Science 1996
203
15

Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
Jian-Ming Yang, Bernhard Hildebrandt, Christoph Luderschmidt, K Michael Pollard. Arthritis Rheum 2003
31
19

The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.
Yoshihide Asano, Hironobu Ihn, Kenichi Yamane, Masahide Kubo, Kunihiko Tamaki. J Invest Dermatol 2003
20
30


Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
Danielle B Ulanet, Fredrick M Wigley, Allan C Gelber, Antony Rosen. Arthritis Rheum 2003
46
15



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.